Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia.
Tefferi
A
A
Elliot
M A
MA
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000139:chemically induced* / Q000209:etiology; D010865:Pilot Projects; D010976:Platelet Count; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000633:toxicity*
D013792:Thalidomide